Horizon Pharma: Rayos FDA Approval Thursday Seems Likely

Perhaps the biggest risk to Horizon going into tomorrow’s FDA approval decision is the stock’s run from $4 to $7.50 over the past six weeks. That’s a big move ahead of a major catalyst and can often lead to a significant sell off once Rayos’ approva…

  Your Reaction?

    Hot Buzz

    Clinton Receives Thirty Times As Much Tech Cash As Trump

    Dear “The Bachelorette”, Please Give Us The Proper Love Story Again


    Now Buzzing